BioSpace News Archive

NEW YORK , Feb. 12, 2020 /PRNewswire/ -- Shepherd, Finkelman, Miller & Shah, LLP is pleased to announce that the Honorable Colleen McMahon, Chief Judge for the United States District Court for the Southern District of New York , recently approved a whistleblower award of 29 percent of the $54 million settlement the firm and its co-counsel reached with Teva Pharmac

Feb. 12, 2020 15:00 UTC WALTHAM, Mass.--( BUSINESS WIRE )-- Palleon Pharmaceuticals , a leading biotech company developing drugs that target the Siglec-Sialoglycan axis to treat cancer, today announced that Li Peng, Ph.D., has been promoted to Chief Scientific Officer. Dr. Peng, who has been integral to the development of Palleon’s platform technologies and has overseen the building of its world-class R&D operations, will be the company’s first CSO. “Li’s imprint on Pall

Projects use positive parenting and sport to help prevent child maltreatment and support young survivors of family violence

Headspace, a global leader in mindfulness and meditation, today announced it raised a total of $93 million in its Series C funding round.

Feb. 12, 2020 15:44 UTC Pharmacy Times Continuing Education™ to Present Three Educational Symposia at the Hematology/Oncology Pharmacy Association 16 th Annual Conference The educational sessions are available live and via simulcast CRANBURY, N.J.--( BUSINESS WIRE )-- Pharmacy Times Continuing Education™ ( PT CE), a leader in continuing education for retail, health-system, managed care, oncology and specialty pharmacists, will conduct three continuing education symposia

4WEB Medical, an orthopedic device company focused on developing innovative implants with an Advanced Structural Design that utilizes its proprietary Truss Implant Technology™, announced today that the company achieved record revenues in 2019.

Arrhythmia detection to further expand monitoring options in cardiology community

Ergotron, a global movement company that builds environments that help people thrive, has partnered with Ingram Micro China to donate medical carts to two hospitals in Wuhan, China, the city at the epicenter of the recent novel coronavirus outbreak.

Feb. 12, 2020 16:45 UTC LYON, France--( BUSINESS WIRE )-- POXEL SA (Euronext: POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH), today announced its cash position and revenue for the twelve months ended December 31, 2019 and provided a corporate update. “Last year we achieved many important milestones. Together with our partner, Su

Agreement capitalizes on artificial intelligence and deep learning to develop therapeutic monoclonal antibodies, including novel bispecific antibodies (BiCKI® platform) Collaboration runs for 3 years and will be used for 6 antibody programs NANTES, France, Feb. 12, 2020 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN: FR0012127173; Mnémo: OSE), today announced a new collaboration agreement with deep technology innovative start-up MAbSilico , located in Tours, France, to use artificia